In the early 2002s, within a small office in Chennai, India, a visionary mission took shape: “ Remotely, access overnight sleep disorder monitoring data from global sleep labs and generate clinical reports with a team of physicians and clinicians.” This revolutionary vision powered our team to securely process critical health information (PHI), meeting all the standards of regulatory compliance from India.
What began as a humble initiative evolved into a groundbreaking approach that redefined critical clinical data processing, in the field of Sleep Disorder, Clinical Cardiology, Clinical trials & ICU’s earning global trust and transforming patient care.
Crafting the Future: Integrating Cutting-Edge AI with Clinical Solutions through Precision and Vision
Over the past fifteen years, we’ve grown our skilled workforce to a thousand employees, scaling proportionately with the expansion of our business. In the fast-paced world of global healthcare, precision deep-AI software isn’t just a luxury; it’s a necessity for the future economics of business scalability.
We have built the next generation of cutting-edge deep AI-driven technology for a host of clinical cardiology analysis and reporting not merely as a technical task but as a form of artistry, where each rhythm detection is clinically perfected. This process retains the timeless values of dedication, refinement, and a passion for delivering unparalleled value to global electrophysiology landscape.
As a company offering advanced AI-driven clinical cardiology analysing and digital monitoring services, our focus has always been on investing in what truly matters—our skilled clinical team in India, NAmericas and the groundbreaking products they create.
We’ve chosen a path that prioritizes independence. By avoiding VCs, and acquisitions, we’ve preserved the freedom to innovate on our own terms. This independence allows us to push boundaries, learn from every experience, and continuously improve. As we look to the future, we’re excited to continue this journey, delivering unparalleled value to global healthcare businesses while staying true to our roots.
We take great pride in our ability to adapt and grow, learning from every challenge and using those insights to seize new opportunities in the Clinical cardiology market.
Our success goes beyond the Clinical services and advanced softwares, we have develop; it’s deeply rooted in the trust we’ve built with our clients and the recognition we’ve earned from industry experts. This trust is a testament to our dedication to continuous innovation, bolstered by our highly skilled clinical team and expert advisors in North America and India.
We’re not just keeping up with the future—we’re actively shaping it.
Rather than relying solely on traditional qualifications and credentials, we focus on the unique potential each person brings. This inclusive approach, along with our dedication to creating jobs in rural communities, helps keep our culture vibrant and dynamic. Our commitment to diversity is also reflected in our workforce—over 60% of our team members are women, contributing their expertise across all levels of our clinical services and software development teams.
These teams, which include professionals with advanced degrees such as Master’s and PhDs, work together with integrity, passion, and a shared sense of purpose. We also prioritize nurturing fresh talent by hiring new graduates directly from campus, ensuring a continuous influx of innovative ideas and perspectives.
The loyalty of our employees speaks volumes about the supportive environment we’ve cultivated: 20% have been with us for over a decade, 18% for two decades, and 6% have been part of Techindia since its inception. We are proud of the strong, inclusive culture we’ve built—one that encourages growth, collaboration, and a deep sense of belonging for everyone.
These investments have been centered around innovations that align closely with our mission, many of which have resulted in successful exits.
Our portfolio includes groundbreaking advancements in areas such as Artificial Super Intelligence (ASI) for disease prediction, molecular and synthetic biology, machine learning for informed decision-making, robotic microsurgery, leadless pacemakers, advanced materials, and more.
Beyond these investments, Techindia has played a crucial role in fostering the growth of these startups by serving on advisory boards and offering deep expertise in clinical cardiology AI/ML. Our highly skilled clinical teams, located in both the USA and India, are dedicated to driving healthcare innovation and supporting the next generation of transformative medical technologies.
With over 450+ American board-certified cardiac techs operating within a 24×7 HIPAA-compliant infrastructure, we are proud to be Asia’s leading employer of fully certified clinical teams.
Through our academy, we provide rigorous training, continuous education, and compliance updates, ensuring our clinicians are equipped to respond to critical rhythms, escalate issues, manage data, personalize notifications, and coordinate life-saving interventions with precision across our global centers.
Compliance is complex and costly, but one misstep can undo years of brand-building, causing irreparable damage to an organization’s reputation and bottom line.
That’s why, before building our AI model, we prioritized robust data policies and controls focused on security, privacy, governance, and compliance. We enforce strict access policies around machine learning datasets and expand threat modeling to address AI-specific risks, such as outputs containing sensitive data or inappropriate content.
We invest heavily in the compliance and security of our infrastructure, ensuring adherence to industry-specific regulatory standards, including HIPAA, CMS, GDPR, and ISO27100.
We’ve been dedicated to delivering exceptional cardiac analysis services to our global clients. In the end, it’s not just the major achievements that count, but the consistent small victories and the relentless determination to keep moving forward.
This is our daily mission: to continually strive and deliver true value to our clients.
Variants of Cardiac and Sleep biosensor integrations
Heart beats processed per day
Touching lives every day globally
Physicians are serviced every day
Countries serviced from our 6 delivery centers
Experience the power of the CRAVE (Cardiac Rhythm AI Visualization Engine) platform, leveraging deep learning to automatically detect 108 arrhythmia classifications with unmatched accuracy. CRAVE operates up to 10 times faster than traditional methods, providing both speed and cost-effectiveness. Supported by a skilled clinical team from the USA and India, CRAVE positions your organization at the cutting edge of data-driven healthcare innovation.
Top arrhythmia classifications
Arrhythmia sub-classifications
Overall rhythm detection accuracy
Trained over critical labeled ECG Beats
Trained over public data and is data & device neutral
Faster than manual processing
